Company / PP&E per Share
Amphstar Pharmaceuticals, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$6.52
FY2025
5-year range
$4.99 / $6.52
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
#13 of 191
Health Care
What the data says
Among 191 Health Care companies, Amphstar Pharmaceuticals, Inc. is in the top 7% for pp&e per share. PP&E per Share has increased for 3 consecutive years, from $4.99 in FY2022 to $6.52 in FY2025.
Based on SEC 10-K filings.
6.52 in FY2025 with a 5-year CAGR of +3.2%. Top quartile in the Health Care sector.
Improved from $5.88 to $6.52 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 191This company $6.52 Sector average $22.34
▼
-70.8% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s pp&e per share has grown for 3 consecutive years.
- In FY2025, pp&e per share increased 5.4% year-over-year.
- Ranks #13 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.52 | +5.4% |
| FY2024 | $6.19 | +5.3% |
| FY2023 | $5.88 | +17.7% |
| FY2022 | $4.99 | -2.9% |
| FY2021 | $5.14 | -7.9% |
| FY2020 | $5.58 | +11.3% |
| FY2019 | $5.02 | +11.1% |
| FY2018 | $4.51 | +15.6% |
| FY2017 | $3.90 | +15.4% |
| FY2016 | $3.38 | +6.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026